Category: Latest News
-
Micron Shares Surge on Powerful Outlook Fueled by AI-Driven Memory Demand
Micron Technology (NASDAQ:MU) shares jumped sharply after the memory chipmaker delivered an upbeat outlook, projecting a significant increase in revenue, profits and record-high margins for the current quarter, underpinned by rising memory prices and robust demand linked to artificial intelligence workloads. The stock was up more than 9% in premarket trading on Thursday by 04:28…
-
Oil Prices Rise Further After Trump Orders Venezuela Tanker Blockade, Though Weekly Drop Looms
Oil prices extended recent gains on Thursday as concerns over global supply intensified following U.S. President Donald Trump’s decision to impose a blockade on sanctioned oil tankers moving in and out of Venezuela. By 04:35 ET (09:35 GMT), February Brent crude futures were up 0.4% at $59.93 a barrel, while U.S. West Texas Intermediate (WTI)…
-
Apple Opens iPhone Ecosystem to Third-Party App Stores in Japan Under New Competition Law
Apple Inc (NASDAQ:AAPL) said on Wednesday that it has begun allowing third-party app stores on iPhones and other devices in Japan, a move made to comply with newly introduced legislation designed to increase competition in the smartphone market. In a statement, Apple said developers in Japan will be able to create and operate their own…
-
Lululemon Shares Jump After Report of $1bn-Plus Elliott Stake Amid CEO Transition
Shares in Lululemon Athletica (NASDAQ:LULU) rose sharply after reports that activist investor Elliott Investment Management has built a stake worth more than $1 billion in the athletic apparel group and is seeking to influence strategic and leadership changes. According to a Wall Street Journal report published on Wednesday, citing people familiar with the situation, Elliott…
-
Dow Jones, S&P, Nasdaq, Wall Street Futures, U.S. Inflation Data, Micron Outlook and BoE Decision Set the Tone for Markets
U.S. equity futures were mostly higher on Thursday, supported by upbeat guidance from semiconductor group Micron (NASDAQ:MU), although investor sentiment remains sensitive ahead of the release of key U.S. inflation figures. In Europe, several central banks are holding policy meetings, with the Bank of England expected to stand out as the only one to cut…
-
U.S. Stocks Move Sharply Lower Amid Renewed Tech Weakness
After ending yesterday’s choppy session narrowly mixed, stocks moved to the upside in early trading on Wednesday but quickly came under pressure. The major averages pulled back well off their highs of the session and firmly into negative territory. The major averages saw further downside going into the end of the day, closing just off…
-
Inspirato Shares Surge on $59 Million Takeover Agreement
Shares of Inspirato Inc. (NASDAQ:ISPO) jumped 46.5% in premarket trading on Wednesday after the luxury vacation club announced it had agreed to be acquired by Exclusive Investments LLC in an all-cash deal priced at $4.27 per share. The transaction values Inspirato at roughly $59 million on a fully diluted basis and represents a premium of…
-
CNS Pharmaceuticals Shares Dip After CEO Departure Announcement
Shares of CNS Pharmaceuticals Inc. (NASDAQ:CNSP) slipped 2.8% on Wednesday after the company disclosed that its Chief Executive Officer, John Climaco, has stepped down from the role. The biopharmaceutical firm, which develops therapies targeting primary and metastatic cancers of the brain and central nervous system, announced that Rami Levin has been appointed President and Chief…
-
DEFSEC Shares Slide Following Announcement of Equity Offering
Shares of DEFSEC Technologies Inc. (NASDAQ:DFSC) dropped 17.7% on Wednesday after the cybersecurity company revealed plans for a registered direct share offering alongside a concurrent private placement involving shares and warrants. Under the terms of the transaction, DEFSEC intends to issue 566,040 common shares at a price of CAD$3.64 (US$2.65) per share through the registered…
-
Processa Pharmaceuticals Shares Surge on Encouraging Cancer Trial Update
Shares of Processa Pharmaceuticals Inc. (NASDAQ:PCSA) jumped 23.8% on Wednesday after the company reported early Phase 2 clinical data indicating that its Next Generation Cancer (NGC) therapy achieved higher exposure to cancer-fighting metabolites while maintaining a safety profile comparable to existing treatments. The clinical-stage biotech company said results from 16 of the 19 patients enrolled…